Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.

The aims of the trial were to establish the response rate and determine the toxicity of combination chemotherapy with ifosphamide, vincristine and cisplatin (HOP regimen) in advanced metastatic seminoma and to study the role of post-chemotherapy consolidation treatment. Patients with bulky metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fosså, S. D., Droz, J. P., Stoter, G., Kaye, S. B., Vermeylen, K., Sylvester, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033625/
https://www.ncbi.nlm.nih.gov/pubmed/7880748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033625/
https://www.ncbi.nlm.nih.gov/pubmed/7880748

Ejemplares similares